Trestatin

N/A

Report date: 2022/02/14 14:30:19
NME

Base Information

Drug NameTrestatin
Drug Alias NameRO-090183RO-090185RO-090184RO-090154
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSalivary alpha-amylase inhibitors
TargetsSalivary alpha-amylase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A